Get started
Author

María‐Carlota Londoño

Observed names: Londono, Maria Carlota, Londono, Maria-Carlota, Londoño Hurtado, María Carlota, Londoño, Maria Carlota, Londoño, María Carlota, Londõno, Maria-Carlota, M Londono, M Londoño, M. Carlota Londoño, M. Londono, M. Londoño, M.-C. Londono, M.-C. Londoño, M.C Londoño, M.C. Londono, M.C. Londoño, M.‐C. Londoño, MC. Londono, Mar??a-Carlota Londo??o, Maria C Londoño, Maria C. Londoño, Maria Carlota Londono, Maria Carlota Londoño, Maria Carlota Londoño,, Maria Londono, Maria-Carlota Londono, Maria-Carlota Londoño, Maria‐Carlota Londono, Maria‐Carlota Londoño, Maria–Carlota Londoño, María C. Londoño, María Carlota Londono, María Carlota Londoño, María Londoño, María-Carlota Londoño, María-Carlota Londoño Hurtado
Institutions: University of Miami, Global Viral, Centro de Investigación Biomédica en Red, Hospital Clínic de Barcelona, Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas, Fundació Clínic per a la Recerca Biomèdica, Consorci Institut D'Investigacions Biomediques August Pi I Sunyer, IRCCS Humanitas Research Hospital, ERN RARE-LIVER, Fundació de Recerca Clínic Barcelona-Institut d’Investigacions Biomèdiques August Pi i Sunyer, Universitat de Barcelona
Observed institutions: Goethe University Frankfurt, University of Miami, Universidad Pontificia Bolivariana, King's College London, Global Viral, Instituto de Salud Carlos III, University of Florida, Centro de Investigación Biomédica en Red, Hospital Clínic de Barcelona, Institut d'Investigacions Biomèdiques de Barcelona, Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas, University Hospital Frankfurt, Hôpital Saint Eloi, Barcelona Institute for Global Health, King's College Hospital, Fundació Clínic per a la Recerca Biomèdica, Consorci Institut D'Investigacions Biomediques August Pi I Sunyer, IRCCS Humanitas Research Hospital, ERN RARE-LIVER, Fundació de Recerca Clínic Barcelona-Institut d’Investigacions Biomèdiques August Pi i Sunyer, Universitat de Barcelona, Medical Research Council
ORCID: 0000-0002-6533-1586
Observed ORCID: 0000-0002-6533-1586
OpenAlex ID: A5067553313
Grazoprevir plus elbasvir in treatment-naive and treatment-experienced patients with hepatitis C virus genotype 1 infection and stage 4–5 chronic kidney disease (the C-SURFER study): a combination phase 3 study
2015 · David Roth, David R Nelson, et al. · The Lancet · 671
PDF
Prospective multicenter clinical trial of immunosuppressive drug withdrawal in stable adult liver transplant recipients
2013 · Carlos Benítez, María-Carlota Londoño, et al. · Hepatology · 318
Effects of All-Oral Anti-Viral Therapy on HVPG and Systemic Hemodynamics in Patients With Hepatitis C Virus-Associated Cirrhosis
2017 · Sabela Lens, Edilmar Alvarado-Tapias, et al. · Gastroenterology · 271
Sofosbuvir compassionate use program for patients with severe recurrent hepatitis C after liver transplantation
2014 · Xavier Forns, Michael Charlton, et al. · Hepatology · 229
PDF
MELD score and serum sodium in the prediction of survival of patients with cirrhosis awaiting liver transplantation
2007 · Maria-Carlota Londoño, Andrés Cárdenas, et al. · Gut · 224
PDF
Intra-graft expression of genes involved in iron homeostasis predicts the development of operational tolerance in human liver transplantation
2011 · Felix Bohne, Marc Martínez-Llordella, et al. · Journal of Clinical Investigation · 210
Hyponatremia Impairs Early Posttransplantation Outcome in Patients With Cirrhosis Undergoing Liver Transplantation
2006 · Maria–Carlota Londoño, Mónica Guevara, et al. · Gastroenterology · 195
Nomenclature, diagnosis and management of drug-induced autoimmune-like hepatitis (DI-ALH): An expert opinion meeting report
2023 · Raúl J. Andrade, Guruprasad P. Aithal, et al. · Journal of Hepatology · 160
PDF
Portal pressure and liver stiffness measurements in the prediction of fibrosis regression after sustained virological response in recurrent hepatitis C
2017 · Ezequiel Mauro, Gonzalo Crespo, et al. · Hepatology · 159
Virologic, Clinical, and Immune Response Outcomes of Patients With Hepatitis C Virus–Associated Cryoglobulinemia Treated With Direct-Acting Antivirals
2016 · Martín Bonacci, Sabela Lens, et al. · Clinical Gastroenterology and Hepatology · 132
Clinical outcomes of patients undergoing antiviral therapy while awaiting liver transplantation
2017 · Juan Manuel Pascasio, Carmen Vinaixa, et al. · Journal of Hepatology · 129
Comparison of Transcriptional and Blood Cell-Phenotypic Markers Between Operationally Tolerant Liver and Kidney Recipients
2011 · J.J. Lozano, A. Pallier, et al. · American Journal of Transplantation · 126
Immunosuppression minimization vs. complete drug withdrawal in liver transplantation
2013 · Maria-Carlota Londoño, Antoni Rimola, et al. · Journal of Hepatology · 118
PDF
Liver injury after SARS‐CoV‐2 vaccination: Features of immune‐mediated hepatitis, role of corticosteroid therapy and outcome
2022 · Cumali Efe, Anand V. Kulkarni, et al. · Hepatology · 117
The efficacy of direct anti-HCV drugs improves early post-liver transplant survival and induces significant changes in waiting list composition
2018 · Gonzalo Crespo, Núria Trota, et al. · Journal of Hepatology · 107
Greater Transplant-Free Survival in Patients Receiving Obeticholic Acid for Primary Biliary Cholangitis in a Clinical Trial Setting Compared to Real-World External Controls
2022 · C. Fiorella Murillo Perez, Holly Fisher, et al. · Gastroenterology · 106
PDF
Long-Term Outcomes of Patients With HCV-Associated Cryoglobulinemic Vasculitis After Virologic Cure
2018 · Martín Bonacci, Sabela Lens, et al. · Gastroenterology · 106
Management of biliary complications after orthotopic liver transplantation: The role of endoscopy
2008 · Maria C Londoño, Domingo Balderramo, et al. · World Journal of Gastroenterology · 99
PDF
Efficacy and tolerability of interferon-free antiviral therapy in kidney transplant recipients with chronic hepatitis C
2016 · Inmaculada Fernández, Raquel Muñoz-Gómez, et al. · Journal of Hepatology · 96
Beneficial Effect of Angiotensin-Blocking Agents on Graft Fibrosis in Hepatitis C Recurrence after Liver Transplantation
2004 · Antoni Rimola, María-Carlota Londoño, et al. · Transplantation · 92
HCV-Induced Immune Responses Influence the Development of Operational Tolerance After Liver Transplantation in Humans
2014 · Felix Bohne, María-Carlota Londoño, et al. · Science Translational Medicine · 90
Another case of autoimmune hepatitis after SARS-CoV-2 vaccination – still casualty?
2021 · Maria-Carlota Londoño, Jordi Gratacós-Ginès, et al. · Journal of Hepatology · 89
PDF
Enhanced recovery for liver transplantation: recommendations from the 2022 International Liver Transplantation Society consensus conference
2022 · Joerg M Pollok, Pascale Tinguely, et al. · ˜The œLancet. Gastroenterology & hepatology · 88
Hepatic Infiltrates in Operational Tolerant Patients After Liver Transplantation Show Enrichment of Regulatory T Cells Before Proinflammatory Genes Are Downregulated
2015 · R. Taubert, R. Danger, et al. · American Journal of Transplantation · 81
PDF
Daclatasvir combined with sofosbuvir or simeprevir in liver transplant recipients with severe recurrent hepatitis C infection
2016 · Robert J. Fontana, Robert S. Brown, et al. · Liver Transplantation · 80
Works count: 316
Citation count: 6,484
H-index: 41
I10-index: 92
Year
Topic
Type